Presentation is loading. Please wait.

Presentation is loading. Please wait.

Antiphospholipid antibodies associated with recurrent pregnancy loss: Prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight.

Similar presentations


Presentation on theme: "Antiphospholipid antibodies associated with recurrent pregnancy loss: Prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight."— Presentation transcript:

1 Antiphospholipid antibodies associated with recurrent pregnancy loss: Prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin  Luis S. Noble, M.D., William H. Kutteh, M.D., Ph.D., Nanette Lashey, M.D., Rodney D. Franklin, B.S., Juan Herrada, M.D.  Fertility and Sterility  Volume 83, Issue 3, Pages (March 2005) DOI: /j.fertnstert Copyright © 2005 American Society for Reproductive Medicine Terms and Conditions

2 FIGURE 1 Allocation of patients with recurrent pregnancy loss and antiphospholipid antibodies to treatment groups. LMWH = low-molecular-weight heparin; UFH = unfractionated heparin; LDA = low dose aspirin (81 mg). Fertility and Sterility  , DOI: ( /j.fertnstert ) Copyright © 2005 American Society for Reproductive Medicine Terms and Conditions


Download ppt "Antiphospholipid antibodies associated with recurrent pregnancy loss: Prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight."

Similar presentations


Ads by Google